Yanni Zhu

5.0k total citations · 1 hit paper
40 papers, 1.1k citations indexed

About

Yanni Zhu is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Yanni Zhu has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Epidemiology and 9 papers in Oncology. Recurrent topics in Yanni Zhu's work include Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). Yanni Zhu is often cited by papers focused on Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). Yanni Zhu collaborates with scholars based in United States, China and France. Yanni Zhu's co-authors include Khalid Shah, Wei Pan, Xiaotong Shen, Evguenia S. Svarovskaia, David Wyles, Diana M. Brainard, John G. McHutchison, Benedetta Massetto, Deepak Bhere and Navid Redjal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Yanni Zhu

39 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial

2022 157 citations Naim Alkhouri, Robert Herring et al. Journal of Hepatology profile →

Peers

Countries citing papers authored by Yanni Zhu

Since Specialization

Citations

This map shows the geographic impact of Yanni Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanni Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanni Zhu more than expected).

Fields of papers citing papers by Yanni Zhu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanni Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanni Zhu. The network helps show where Yanni Zhu may publish in the future.

Co-authorship network of co-authors of Yanni Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanni Zhu. A scholar is included among the top collaborators of Yanni Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanni Zhu. Yanni Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	N6-methyladenosine-modified circPLPP4 sustains cisplatin resistance in ovarian cancer cells via PIK3R1 upregulation 2024 ·Molecular Cancer ·Han Li, Run Lin, Yanna Zhang, Yanni Zhu, Shuting Huang, Jing Lan, Nian Lu, (unknown), (unknown), Weijing Zhang	22
2	Host–Guest Doping Strategy Enables Efficient Perovskite Light-Emitting Diodes with Suppressed Roll-Off 2024 ·ACS Applied Electronic Materials ·(unknown), (unknown), (unknown), (unknown), Yanni Zhu, Lijun Qi, Jie Hua, Xi Yuan, Gang Zhang, (unknown), Jianan Dai, Jin Wang	1
3	Efficient Quasi-Two-Dimensional Perovskite Light-Emitting Diodes Achieved through the Passivation of Multi-Fluorine Phosphate Molecules 2024 ·Micromachines ·(unknown), (unknown), (unknown), (unknown), Yanni Zhu, Jie Hua, Gang Zhang, Chen Chen, (unknown), Jin Wang, Chao You	3
4	Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer 2024 ·npj Breast Cancer ·Sara A. Hurvitz, Aditya Bardia, Kevin Punie, Kevin Kalinsky, Lisa A. Carey, Hope S. Rugo, Véronique Dièras, (unknown), Rosemary Delaney, Yanni Zhu, Sara M. Tolaney	19
5	Fate and Efficacy of Engineered Allogeneic Stem Cells Targeting Cell Death and Proliferation Pathways in Primary and Brain Metastatic Lung Cancer 2023 ·Stem Cells Translational Medicine ·Susana Moleirinho, Yohei Kitamura, (unknown), (unknown), (unknown), David Y.B. Deng, Nobuhiko Kanaya, David Kozono, (unknown), Jeffrey J. Gray, (unknown), Yanni Zhu, Khalid Shah	2
6	The interactive effects of extrinsic and intrinsic motivations on service recovery performance: the mediating role of self-efficacy 2023 ·Tourism & Management Studies ·Yanni Zhu, (unknown), (unknown), Huiying Lin, (unknown), (unknown)	2
7	Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial breakdown → 2022 ·Journal of Hepatology ·Naim Alkhouri, Robert Herring, Heidi Kabler, Zeid Kayali, Tarek Hassanein, Anita Kohli, Ryan S. Huss, Yanni Zhu, Andrew N. Billin, (unknown), Kristine Buchholtz, Mette Skalshøi Kjær, Clare A. Balendran, Robert P. Myers, Rohit Loomba, Mazen Noureddin	157
8	Sacituzumab govitecan as second-line treatment for metastatic triple-negative breast cancer—phase 3 ASCENT study subanalysis 2022 ·npj Breast Cancer ·Lisa A. Carey, Delphine Loirat, Kevin Punie, Aditya Bardia, Véronique Dièras, Florence Dalenc, Jennifer R. Diamond, Christel Fontaine, Grace Wang, Hope S. Rugo, Sara A. Hurvitz, Kevin Kalinsky, Joyce O’Shaughnessy, Sibylle Loibl, Luca Gianni, Martine Piccart, Yanni Zhu, Rosemary Delaney, (unknown), Javier Cortés	37
9	An Online Contaminant Classification Method Based on MF-DCCA Using Conventional Water Quality Indicators 2020 ·Processes ·Yanni Zhu, Kexin Wang, (unknown), (unknown), Dibo Hou, Jie Yu, Pingjie Huang, Guangxin Zhang	8
10	The involvement of the mGluR5-mediated JNK signaling pathway in rats with diabetic retinopathy 2019 ·International Ophthalmology ·Yanni Zhu, (unknown), Qi Wang, Xiaohong Chen, (unknown), Shu Zhang	5
11	Bi-specific molecule against EGFR and death receptors simultaneously targets proliferation and death pathways in tumors 2017 ·Scientific Reports ·Yanni Zhu, (unknown), Clemens Reinshagen, Deepak Bhere, Michal O. Nowicki, Sean Lawler, Jérémie Roux, Khalid Shah	32
12	Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION Trials 2016 ·Clinical Infectious Diseases ·Jason Grebely, Stefan Mauss, Ashley Brown, Jean–Pierre Bronowicki, Massimo Puoti, David Wyles, (unknown), Yanni Zhu, (unknown), Bruce Kreter, Diana M. Brainard, Chohee Yun, (unknown), Gregory J. Dore	71
13	Multifunctional receptor-targeting antibodies for cancer therapy 2015 ·The Lancet Oncology ·Yanni Zhu, (unknown), Khalid Shah	36
14	Safety and efficacy of ledipasvir‐sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data 2015 ·Hepatology ·Julius Wilder, Lennox J. Jeffers, Natarajan Ravendhran, Mitchell L. Shiffman, John Poulos, Mark Sulkowski, Norman Gitlin, Kimberly Workowski, Yanni Zhu, Jenny C. Yang, Phillip S. Pang, John G. McHutchison, Andrew J. Muir, Charles D. Howell, Kris V. Kowdley, Nezam H. Afdhal, K. Rajender Reddy	49
15	Multiple lesions in receptor tyrosine kinase pathway determine glioblastoma response to pan-ERBB inhibitor PF-00299804 and PI3K/mTOR dual inhibitor PF-05212384 2014 ·Cancer Biology & Therapy ·Yanni Zhu, Khalid Shah	29
16	All-Oral Combination of Ledipasvir, Vedroprevir, Tegobuvir, and Ribavirin in Treatment-Naïve Patients With Genotype 1 HCV Infection 2014 ·Hepatology ·David Wyles, M. Rodríguez‐Torres, Eric Lawitz, Mitchell L. Shiffman, Stanislas Pol, Robert W. Herring, Benedetta Massetto, Bittoo Kanwar, (unknown), (unknown), Yanni Zhu, Hongmei Mo, Diana M. Brainard, Mani Subramanian, John G. McHutchison, François Habersetzer, Mark Sulkowski	38
17	Interferon γ–Induced Protein10 Kinetics in Treatment-Naive Versus Treatment-Experienced Patients Receiving Interferon-Free Therapy for Hepatitis C Virus Infection: Implications for the Innate Immune Response 2014 ·The Journal of Infectious Diseases ·Jennifer Lin, François Habersetzer, M. Rodríguez‐Torres, Nezam H. Afdhal, Eric Lawitz, Matthew Paulson, Yanni Zhu, G. Subramanian, John G. McHutchison, Mark Sulkowski, David Wyles, Robert T. Schooley	16
18	Validation of genetic variants associated with early acute rejection in kidney allograft transplantation 2011 ·Clinical Transplantation ·William S. Oetting, Yanni Zhu, Marcia J. Brott, Arthur J. Matas, (unknown), Wei Pan	10
19	Transgenic Expression of Polyomavirus Middle T Antigen in the Mouse Prostate Gives Rise to Carcinoma 2011 ·Journal of Virology ·Sang‐Hyun Lee, Shidong Jia, Yanni Zhu, Tamara Utermark, Sabina Signoretti, Massimo Loda, Brian Schaffhausen, Thomas M. Roberts	6
20	Network-based support vector machine for classification of microarray samples 2009 ·BMC Bioinformatics ·Yanni Zhu, Xiaotong Shen, Wei Pan	80

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact